also known hydroxyamfetamine hydroxyamphetamine oxamphetamine norpholedrine parahydroxyamphetamine Î±methyltyramine drug stimulates sympathetic nervous system used medically eye drops dilate pupil process called mydriasis back eye examined also major metabolite amphetamine certain substituted amphetamines used eye drops dilate pupil process called mydriasis back eye examined diagnostic test horners syndrome patients horners syndrome exhibit anisocoria brought lesions nerves connect nasociliary branch ophthalmic application eye indicate whether lesion preganglionic postganglionic based pupils response pupil dilates lesion preganglionic pupil dilate lesion limitations use diagnostic tool intended immediate follow another mydriatic drug cocaine apraclonidine patient must wait anywhere day week also tendency falsely localize lesions false localization arise cases acute onset cases postganglionic lesion present nerve still responds residual norepinephrine cases unrelated nerve damage masks presence preganglionic like amphetamine agonist human acts indirect sympathomimetic causes release norepinephrine nerve synapses leads mydriasis pupil decreases metabolism serotonin certain monoamines inhibiting activity family enzymes called monoamine oxidases maos particularly type maoacitation needed inhibition maoa prevents metabolism serotonin catecholamines presynaptic terminal thus increases amount neurotransmitters available release synaptic major metabolite amphetamine minor metabolite methamphetamine humans amphetamine metabolized member cytochrome superfamily found metabolized dopamine betahydroxylase eliminated hydroxyamphetamine component two controlled prescription namebrand ophthalmic mydriatics paredrine paremyd paredrine consists solution hydroxyamphetamine paremyd consists combination hydroxyamphetamine hydrobromide trade name rights patents new drug applications ndas two formulations exchanged among different manufacturers shortage raw material required production caused drugs indefinitely removed around akorn inc obtained rights paredrine company reintroduced paremyd market fast acting ophthalmic mydriatic stimulants phenylethanolamine